|
1999 Journal Article Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitroWalsh, M. D., Luckie, S. M., Cummings, M. C., Antalis, T. M. and McGuckin, M. A. (1999). Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro. Breast Cancer Research & Treatment, 58 (3), 253-264. doi: 10.1023/A:1006345301364 |
|
1999 Conference Publication Identification and characterisation of novel mucin genesWilliams, S., Antalis, T. M., Gotley, D. C. and McGuckin, M. A. (1999). Identification and characterisation of novel mucin genes. Australian Gastroenterology Week 1999, Brisbane Convention Centre, 4th - 8th October, 1999. Carlton, Vic: Blackwell Science Asia. |
|
1998 Journal Article Peritoneal fluid from ovarian cancer patients stimulates MUC1 epithelial mucin expression in ovarian cancer cell linesMunster, DJ, Quin, RJ, Bansal, AS, Ward, BG and McGuckin, MA (1998). Peritoneal fluid from ovarian cancer patients stimulates MUC1 epithelial mucin expression in ovarian cancer cell lines. International Journal of Cancer, 76 (3), 393-398. doi: 10.1002/(SICI)1097-0215(19980504)76:33.0.CO;2-C |
|
1998 Journal Article Progesterone stimulates production and secretion of MUC1 epithelial mucin in steroid-responsive breast cancer cell linesMcGuckin, MA, Quin, RJ and Ward, BG (1998). Progesterone stimulates production and secretion of MUC1 epithelial mucin in steroid-responsive breast cancer cell lines. International Journal of Oncology, 12 (4), 939-945. doi: 10.3892/ijo.12.4.939 |
|
1998 Journal Article Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy womenRichards, ER, Devine, PL, Quin, RJ, Fontenot, JD, Ward, BG and McGuckin, MA (1998). Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy women. Cancer Immunology Immunotherapy, 46 (5), 245-252. doi: 10.1007/s002620050484 |
|
1997 Journal Article Expression of MUC1 and MUC2 mucins in epithelial ovarian tumoursDong, Y, Walsh, MD, Cummings, MC, Wright, RG, Khoo, SK, Parsons, PG and McGuckin, MA (1997). Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours. Journal of Pathology, 183 (3), 311-317. doi: 10.1002/(SICI)1096-9896(199711)183:33.0.CO;2-2 |
|
1997 Journal Article Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancerDong, Y, Walsh, MD, McGuckin, MA, Cummings, MC, Gabrielli, BG, Wright, GR, Hurst, T, Khoo, SK and Parsons, PG (1997). Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer. International Journal of Cancer, 74 (4), 407-415. doi: 10.1002/(SICI)1097-0215(19970822)74:43.0.CO;2-Z |
|
1997 Journal Article Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product p16(INK4A) in ovarian cancer is associated with progression and unfavourable prognosisDong, Y, Walsh, MD, McGuckin, MA, Gabrielli, BG, Cummings, MC, Wright, RC, Hurst, T, Khoo, SK and Parsons, PG (1997). Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product p16(INK4A) in ovarian cancer is associated with progression and unfavourable prognosis. International Journal of Cancer, 74 (1), 57-63. doi: 10.1002/(SICI)1097-0215(19970220)74:13.0.CO;2-F |
|
1996 Journal Article Occult axillary node metastases in breast cancer: Their detection and prognostic significanceMcGuckin, M. A., Cummings, M. C., Walsh, M. D., Hohn, B. G., Bennett, I. C. and Wright, R. G. (1996). Occult axillary node metastases in breast cancer: Their detection and prognostic significance. British Journal of Cancer, 73 (1), 88-95. doi: 10.1038/bjc.1996.16 |
|
1996 Journal Article Early steps in the biosynthesis of MUC2 epithelial mucin in colon cancer cellsMcGuckin M.A., Devine P.L. and Ward B.G. (1996). Early steps in the biosynthesis of MUC2 epithelial mucin in colon cancer cells. Biochemistry and Cell Biology, 74 (1), 87-93. doi: 10.1139/o96-009 |
|
1995 Journal Article Prostate-specific antigen (PSA) and cancer-associated serum antigen (CASA) in distinguishing benign and malignant prostate diseaseDevine, PL, Walsh, MD, McGuckin, MA, Quin, RJ, Hohn, BG, Claque, A and Samaratunga, H (1995). Prostate-specific antigen (PSA) and cancer-associated serum antigen (CASA) in distinguishing benign and malignant prostate disease. International Journal of Biological Markers, 10 (4), 221-225. doi: 10.1177/172460089501000406 |
|
1995 Journal Article CA15-3, CASA, MSA, AND TPS AS DIAGNOSTIC SERUM MARKERS IN BREAST-CANCERDEVINE, PL, DUROUX, MA, QUIN, RJ, MCGUCKIN, MA, JOY, GJ, WARD, BG and POLLARD, CW (1995). CA15-3, CASA, MSA, AND TPS AS DIAGNOSTIC SERUM MARKERS IN BREAST-CANCER. Breast Cancer Research and Treatment, 34 (3), 245-251. doi: 10.1007/BF00689716 |
|
1995 Journal Article Prognostic-Significance of Muc1 Epithelial Mucin Expression in Breast-CancerMcGuckin, MA, Walsh, MD, Hohn, BG, Ward, BG and Wright, RG (1995). Prognostic-Significance of Muc1 Epithelial Mucin Expression in Breast-Cancer. Human Pathology, 26 (4), 432-439. doi: 10.1016/0046-8177(95)90146-9 |
|
1995 Journal Article THE MUCIN MARKER, CASA, IN OVARIAN-CANCERMCGUCKIN, MA and DEVINE, PL (1995). THE MUCIN MARKER, CASA, IN OVARIAN-CANCER. Tumordiagnostik & Therapie, 16 (1), 1-6. |
|
1995 Journal Article Predictive value of the combination of serum markers, CA125, CASA and TPS in ovarian cancerDevine, PL, McGuckin, MA, Quin, RJ and Ward, BG (1995). Predictive value of the combination of serum markers, CA125, CASA and TPS in ovarian cancer. International Journal of Gynecological Cancer, 5 (3), 170-178. doi: 10.1046/j.1525-1438.1995.05030170.x |
|
1995 Journal Article Heterogeneity in production, secretion and glycosylation of MUC1 epithelial mucin by primary cultures of ovarian carcinomaMcGuckin M.A., Hurst T.G. and Ward B.G. (1995). Heterogeneity in production, secretion and glycosylation of MUC1 epithelial mucin by primary cultures of ovarian carcinoma. International Journal of Cancer, 63 (3), 412-418. doi: 10.1002/ijc.2910630319 |
|
1995 Journal Article The mucin marker, CASA, in ovarian cancerMcGuckin M.A. and Devine P.L. (1995). The mucin marker, CASA, in ovarian cancer. Tumor Diagnostik und Therapie, 16 (1), 1-6. |
|
1994 Journal Article Effect of Interferon-Gamma and Tumor-Necrosis-Factor-Alpha On Sensitivity to Cisplatin in Ovarian-Carcinoma Cell-LinesClark, S, McGuckin, MA, Hurst, T and Ward, BG (1994). Effect of Interferon-Gamma and Tumor-Necrosis-Factor-Alpha On Sensitivity to Cisplatin in Ovarian-Carcinoma Cell-Lines. Cancer Immunology Immunotherapy, 39 (2), 100-104. doi: 10.1007/BF01525315 |
|
1994 Journal Article Serum markers Casa, Cea, Cyfra-21-1, Msa, Nse, Tpa and Tps in lung-cancerDevine, P.L., Yarker, J.Y., Fong, K.M., McGuckin, M.A., Scells, B., Ward, B.G., Thynne, G.S. and Zimmerman, P.V. (1994). Serum markers Casa, Cea, Cyfra-21-1, Msa, Nse, Tpa and Tps in lung-cancer. International Journal of Oncology, 4 (5), 1129-1135. |
|
1994 Journal Article Serum markers CASA, CEA, CYFRA 21-1, MSA, NSE, TPA and TPS in lung cancerDevine, P. L., Yarker, J. Y., Fong, K. M., McGuckin, M. A., Scells, B., Ward, B. G., Thynne, G. S. and Zimmerman, P. V. (1994) Serum markers CASA, CEA, CYFRA 21-1, MSA, NSE, TPA and TPS in lung cancer. International Journal of Oncology, 4 5: 1129-1134. |
